Search

Your search keyword '"Longy, M"' showing total 398 results

Search Constraints

Start Over You searched for: Author "Longy, M" Remove constraint Author: "Longy, M"
398 results on '"Longy, M"'

Search Results

3. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

4. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

5. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

6. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

7. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

8. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers.

9. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

10. Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

11. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

13. A refined molecular taxonomy of breast cancer

16. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

17. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

18. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

19. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

24. Abstract P5-09-07: Risk reducing strategy in germline BRCA mutated patients with locally advanced breast cancer. Establishing mastectomy as a preventing procedure of local recurrence

25. Increased incidence of pathogenic variants in ATMin the context of testing for breast and ovarian cancer predisposition

27. Oral contraceptive use and breast cancer risk: Retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study.

28. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

29. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

30. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families

31. Intra-observer agreement in single and joint double readings of contrast-enhanced breast MRI screening for women with high genetic breast cancer risks

32. Abstract P5-16-23: Rapid germline BRCA screening for locally advanced breast cancer changes surgical procedure after neoadjuvant chemotherapy

33. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

34. Polymorphisms in BRCA1 and 17[Beta]-hydroxysteroid dehydrogenase 2 (EDH17B2) genes as modifiers of ovarian cancer risk in carriers of BRCA1 germline mutations

36. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

38. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

39. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

43. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

44. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

45. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

46. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

47. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families

48. A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)

49. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma‐prone families from three continents

50. Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

Catalog

Books, media, physical & digital resources